ZEJULA once-daily oral: Maintenance treatment for women with recurrent ovarian cancer following CR or PR to platinum-based chemotherapy (Non-PSONS), Seattle 1/30

Posted on 05. Jan, 2018 by in non-PSONS

ZEJULA

Once-Daily Oral Maintenance treatment for women with recurrent ovarian cancer following CR or PR to platinum-based chemotherapy
The First and Only Once-Daily Oral Parp Inhibitor Approved for Use Regardless of BRCA Status
 
Presented by:
DAN VELJOVICH, MD
Gynecologic Oncologist, Pacific Gynecologic Specialists
Swedish Medical Center and Associate
Clinical Professor, University of Washington Department of OB/GYN
Division of Gynecology, Seattle
 
TUESDAY, JANUARY 30, 2018
6:30PM
Daniel’s Broiler
809 Fairview Place North
Seattle, WA  98109
 
RSVP
Limited seating is available. Please RSVP to Colleen Chapman by January 29, 2018, at: cchapman@tesarobio.com or 360-527-5046.
 
Attendees may opt out of the meal by indicating so in their RSVP.
Click here to download flyer: Veljovich Invitation Jan 30

Comments are closed.